Genelux Corp. (GNLX)
2.66
-0.22
(-7.64%)
USD |
NASDAQ |
Aug 28, 16:00
2.665
0.00 (0.00%)
After-Hours: 20:00
Genelux Price to Book Value : 7.446 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 7.446 |
| August 27, 2026 | 8.062 |
| August 26, 2026 | 7.642 |
| August 25, 2026 | 7.614 |
| August 24, 2026 | 7.614 |
| August 21, 2026 | 7.614 |
| August 20, 2026 | 7.670 |
| August 19, 2026 | 7.502 |
| August 18, 2026 | 7.278 |
| August 17, 2026 | 7.558 |
| August 14, 2026 | 7.670 |
| August 13, 2026 | 7.362 |
| August 12, 2026 | 7.558 |
| August 11, 2026 | 7.418 |
| August 10, 2026 | 7.614 |
| August 07, 2026 | 7.446 |
| August 06, 2026 | 7.558 |
| August 05, 2026 | 7.026 |
| August 04, 2026 | 7.894 |
| August 03, 2026 | 8.342 |
| July 31, 2026 | 8.230 |
| July 30, 2026 | 8.538 |
| July 29, 2026 | 7.922 |
| July 28, 2026 | 8.174 |
| July 27, 2026 | 8.258 |
| Date | Value |
|---|---|
| July 24, 2026 | 8.090 |
| July 23, 2026 | 8.286 |
| July 22, 2026 | 8.286 |
| July 21, 2026 | 8.090 |
| July 20, 2026 | 8.202 |
| July 17, 2026 | 8.034 |
| July 16, 2026 | 7.894 |
| July 15, 2026 | 8.146 |
| July 14, 2026 | 8.090 |
| July 13, 2026 | 8.286 |
| July 10, 2026 | 8.482 |
| July 09, 2026 | 8.342 |
| July 08, 2026 | 8.286 |
| July 07, 2026 | 8.314 |
| July 06, 2026 | 8.454 |
| July 02, 2026 | 8.370 |
| July 01, 2026 | 8.118 |
| June 30, 2026 | 8.426 |
| June 29, 2026 | 5.673 |
| June 26, 2026 | 5.615 |
| June 25, 2026 | 5.673 |
| June 24, 2026 | 5.575 |
| June 23, 2026 | 5.712 |
| June 22, 2026 | 5.712 |
| June 18, 2026 | 5.800 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Arcutis Biotherapeutics, Inc. | 13.54 |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
| Anika Therapeutics, Inc. | 2.057 |
| Savara, Inc. | 7.520 |
Price to Book Value Related Metrics
| PS Ratio | 13691.48 |
| PEG Ratio | -2.366 |
| Price | 2.66 |
| Earnings Yield | -32.63% |
| Market Cap | 119.98M |
| PEGY Ratio | -2.366 |